Glimepiride-d4-2

Glimepiride-d4-2 (GliAmperide-d4-2) is deuterium labeled Glimepiride. Glimepiride (Glimperide) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg.

Product Specifications

CAS Number

[1131981-32-2]

Product Name Alternative

Glimperide-d4-2; HOE-490-d4-2

UNSPSC

12352005

Target

Amyloid-β; Isotope-Labeled Compounds

Related Pathways

Neuronal Signaling; Others

Applications

Neuroscience-Neurodegeneration

Field of Research

Metabolic Disease

Smiles

C[C@H](CC1)CC[C@@H]1NC(NS(C(C([2H])=C2[2H])=C([2H])C([2H])=C2CCNC(N3C(C(CC)=C(C3)C)=O)=O)(=O)=O)=O

Molecular Formula

C24H30D4N4O5S

Molecular Weight

494.64

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Geisen, K., Special pharmacology of the new sulfonylurea glimepiride. Arzneimittelforschung, 1988. 38 (8) : p. 1120-30.|[3]Liu, F., et al., Glimepiride attenuates Abeta production via suppressing BACE1 activity in cortical neurons. Neurosci Lett, 2013. 557 Pt B: p. 90-4.|[4]Basit, A., M. Riaz, and A. Fawwad, Glimepiride: evidence-based facts, trends, and observations (GIFTS) . [corrected]. Vasc Health Risk Manag, 2012. 8: p. 463-72.